Benjamin Hickey

Companies

• Bristol-Myers SquibbPresident Mar 4, 2024 to now¹
• Mural Oncology plcBoard member Nov 7, 2023 to now²
• Mirati Therapeutics, Inc.EVP, Chief Commercial Officer Jan 8, 2020 to Jan 23, 2024³
• Surface Oncology, Inc.Board member Dec 16, 2021 to Jun 10, 2022⁴
• Halozyme TherapeuticsSVP, Chief Commercial Officer Sep 14, 2018 to Oct 1, 2019⁵

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Bristol-Myers Squibb BMY16,672 shares⁶$1.0M at $60.95Feb 27, 2026
• MTMirati Therapeutics, Inc.0 shares⁷Jan 23, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

• Feb 27, 2026Shares withheld for tax 1,672 shares at $62.37 of Bristol-Myers Squibb⁶
• Feb 27, 2026Exercised options 3,286 shares of Bristol-Myers Squibb⁶
• Feb 1, 2026Shares withheld for tax 3,810 shares at $55.05 of Bristol-Myers Squibb⁸
• Feb 1, 2026Exercised options 10,079 shares of Bristol-Myers Squibb⁸
• May 9, 2025Sold 97 shares at $38.01 of Bristol-Myers Squibb⁹
• Mar 1, 2025Shares withheld for tax 1,630 shares at $59.62 of Bristol-Myers Squibb¹⁰
• Mar 1, 2025Exercised options 3,286 shares of Bristol-Myers Squibb¹⁰
• Feb 1, 2025Shares withheld for tax 3,725 shares at $58.95 of Bristol-Myers Squibb¹¹
• Feb 1, 2025Exercised options 10,078 shares of Bristol-Myers Squibb¹¹
• Jan 23, 2024Returned to company 17,021 shares of Mirati Therapeutics, Inc.⁷
• Jan 23, 2024Returned to company 72,206 shares of Mirati Therapeutics, Inc.⁷
• Jan 23, 2024Returned to company 27,801 shares of Mirati Therapeutics, Inc.⁷
• Jan 16, 2024Sold 631 shares at $59.02 of Mirati Therapeutics, Inc.¹²
• Jan 16, 2024Sold 966 shares at $59.02 of Mirati Therapeutics, Inc.¹²
• Jan 8, 2024Sold 2,090 shares at $58.92 of Mirati Therapeutics, Inc.¹³
• Dec 29, 2023Granted 17,021 shares at $58.75 of Mirati Therapeutics, Inc.¹⁴
• Dec 13, 2023Sold 2,220 shares at $56.67 of Mirati Therapeutics, Inc.¹⁵
• Aug 9, 2023Granted 22,297 shares at $37.00 of Mirati Therapeutics, Inc.¹⁶
• Jan 20, 2023Granted 36,394 shares of Mirati Therapeutics, Inc.¹⁷
• Jan 17, 2023Sold 619 shares at $42.38 of Mirati Therapeutics, Inc.¹⁸
• Jan 17, 2023Sold 947 shares at $42.38 of Mirati Therapeutics, Inc.¹⁸
• Jan 9, 2023Sold 2,088 shares at $45.37 of Mirati Therapeutics, Inc.¹⁹
• Dec 21, 2022Sold 3,248 shares at $40.41 of Mirati Therapeutics, Inc.²⁰
• Dec 19, 2022Granted 19,149 shares of Mirati Therapeutics, Inc.²⁰
• Jan 18, 2022Sold 627 shares at $120.48 of Mirati Therapeutics, Inc.²¹